SMS Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

709.26

522.05

519.87

563.18

411.95

Operating profit

116.84

54.70

114.48

121.11

79.92

Interest

23.46

21.92

18.88

11.16

12.21

Gross profit

97.85

37.68

100.81

113.40

72.82

EPS (Rs)

5.84

0.48

8.04

7.20

3.86

Other income

4.46

4.89

5.20

3.45

5.11

Stock adjustment

-1.00

36.08

-112.50

26.73

-13.14

Raw material

425.04

299.53

387.80

313.27

259.50

Power and fuel

-

-

-

-

-

Employee expenses

64.15

55.04

51.02

41.17

39.35

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

104.23

76.69

79.07

60.90

46.31

Provisions made

-

-

-

-

-

Depreciation

31.52

32.13

32.15

22.28

22.07

Taxation

16.91

1.47

0.62

30.16

18.07

Net profit / loss

49.42

4.08

68.04

60.96

32.69

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

8.47

8.47

8.47

8.47

8.47

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

16.47

10.48

22.02

21.50

19.40

GPM (%)

13.71

7.15

19.20

20.01

17.46

NPM (%)

6.92

0.78

12.96

10.76

7.84